(Q33374338)

26 July 2017

title

Gemcitabine-oxaliplatin combination in heavily pretreated metastatic breast cancer: a pilot study on 43 patients (English)

1 reference

26 July 2017

main subject

metastatic breast cancer

1 reference

Thibaut Caruba

1

1 reference

26 July 2017

Paul-Henri Cottu

2

1 reference

26 July 2017

Isabelle Madelaine-Chambrin

3

1 reference

26 July 2017

Marc Espié

4

1 reference

26 July 2017

Jean-Louis Misset

5

1 reference

26 July 2017

Marine Gross-Goupil

6

1 reference

26 July 2017

publication date

1 March 2007

1 reference

26 July 2017

1 reference

26 July 2017

volume

13

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

165-171

1 reference

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00391.X

Gemcitabine doublets in advanced urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00391.X

Single-agent gemcitabine is active in previously treated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00391.X

Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00391.X

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00391.X

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00391.X

Gemcitabine and targeted therapy in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00391.X

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4741.2007.00391.X

10.1111/J.1524-4741.2007.00391.X

21 January 2018

Identifiers

DOI

1 reference

release_gkkpdhg3sbfajiyyuhxwwddtqa

26 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gkkpdhg3sbfajiyyuhxwwddtqa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference